Antiretroviral therapy to treat and prevent HIV/AIDS in resource-poor settings

Nature Medicine

Volumn 8, Issue 7, 2002, Pages 651-654

  Garnett, Geoff P ^a   Bartley, Lucy ^a   Grassly, Nicholas C ^a   Anderson, Roy M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COST EFFECTIVENESS ANALYSIS; COUNSELING; DEVELOPING COUNTRY; DRUG EFFICACY; DRUG HALF LIFE; ETHICS; FINANCIAL MANAGEMENT; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH ECONOMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SEXUAL TRANSMISSION; SIDE EFFECT; TREATMENT OUTCOME; TUBERCULOSIS; UNITED NATIONS; VIREMIA; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION; WORLD HEALTH ORGANIZATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; DEVELOPING COUNTRIES; HIV INFECTIONS; HUMANS; POVERTY; UNITED NATIONS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036064208     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0702-651     Document Type: Review

References (28)

1. AIDS and HIV infection in the United Kingdom
2. Resource needs for HIV/AIDS
3. Global Fund makes historic first round of payments
4. AIDS and global justice: Resources from the global AIDS fund must reach the poorest
5. We all have AIDS: Case for reducing the cost of HIV drugs to zero
6. Community-based approaches to the control of multidrug resistance tuberculosis: Introducing DOTS-plus
7. Preventing antiviral anarchy in sub-Saharan Africa
8. Drug-resistant tuberculosis in South African gold miners: Incidence and associated factors
9. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana
10. Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998
11. Acquired anti-tuberculosis drug resistance in Yaounde, Cameroon
12. High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Cote d'lvoire
13. Resistance to antiretroviral treatment in Gabon: Need for implementation of guidelines on antiretroviral therapy use and HIV- 1 drug resistance monitoring in developing countries
14. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after one year of follow-up
15. Transmission of antiretroviral-drug-resistant HIV-1 variants
16. HIV-1 drug resistance in newly infected individuals
17. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda
18. Potential of community-wide chemotherapy or immunotherapy to control the spread of HIV-1
19. Gay men report high rates of unprotected anal sex with partners of unknown or discordant HIV status
20. Increase in high risk sexual behavior among homosexual men, London 1996-8: Cross sectional, questionnaire study
21. Sexual risk behavior increases and is associated with HIV optimism among HIV-negative and HIV-positive gay men in Sydney over the 4 year period to February 2000
22. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco
23. Cost-effectiveness of voluntary HIV-1 counseling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania